PROPERTY: Site To Be Adjacent to Planned Port of Entry
Site work is wrapping up on the $40 million first phase of what will become the 311-acre Otay Crossings Commerce Center at the eastern edge of Otay Mesa.
According to a press release, the project kicks off immediately and surfing is anticipated to commence November 2020
According to a press release, the terms of the deal were undisclosed.
Mundipharma’s Backing Will Extend Runway, Provide Well-Positioned Support
Clinical trial results have yielded a major payout for Cidara Therapeutics, a San Diego company developing an antifungal drug.
Zeakal raised $15 million in funding from Canopy Rivers, Finistere Ventures and Middleland Capital.
AUTO: The All Electric Polestar 2 to Be Sold in 2020 Starting at $63,000
According to reports, five percent of all vehicles sales in San Diego County are electric, and that number continues to grow.
Unpasteurized Beverages Expected to Bring in 2019 Sales of $3.5M+
Sol-ti, an unpasteurized organic “living” beverage line stored in glass bottles, is available in stores like Whole Foods Market.
MANUFACTURING: The System Supports Workers Doing Various Tasks
The product went to market in 2017 with its Airframe Exoskeleton, an upper body exoskeleton device.
Pharma: Rare Finds Pay Off for Cos., Patients
San Diego County biotechs are banking on companies’ scrapped or stalled ideas, including Impact Biomedicines, Kura Oncology and Mirum Pharmaceuticals.
Retail: Self-Promotion Got Product in Spotlight
The nut butter’s journey from kitchen to big-box grocers is a tale of entrepreneurship, timing and — yes — love.
According to Two Roots, this is the first entry in a series of nationwide expansion for the company’s non-alcoholic lager, IPA, wheat and seasonal styles.
According to the release, Jon Kossow, managing partner at Norwest, will join Vuori’s board of directors as part of the agreement. No other terms were disclosed as of press time.
Ionis Having Good Discussions With FDA on Other Therapeutic
Ionis Pharmaceuticals’ drug for a muscle-wasting disease continues to be the company’s main driver of growth, with competition looming.
The third annual report was provided by the California State University San Marcos Office of Business Research & Analysis and the San Diego Brewers Guild.